SEARCH RESULTS

5751 RESULTS

LY3372689

THERAPEUTICS N-[4-fluoro-5-[[2-methyl-4-[(5-methyl-1,2,4-oxadiazol-3-yl)methoxy]piperidin-1-yl]methyl]-1,3-thiazol-2-yl]acetamide Eli Lilly & Co. Small Molecule Tau Between February and June 2019, Lilly conducted Phase 1 safety testing of in LY3372689 in healthy a

Current Filters

  • Date Range : Jun 2020 to Sep 2020 x

Remove all filters

Filter By

DATE RANGE
  • All
  • Past 7 Days
  • Past 30 Days
  • Past 90 Days
  • Past 12 Months
  • Specific Dates
    1. From
      To

TYPE